Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oseltamivir Exposure in Pregnancy Registry and Risk Analysis
ChiCTR2000034920Phase 4Not yet recruiting
- Sponsor
- Beijing Obstetric & Gynecology Hospital, Capital Medical University
- Start
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of oseltamivir in influenza, sponsored by Beijing Obstetric & Gynecology Hospital, Capital Medical University. Primary endpoints: Fetal congenital malformations and Adverse drug reactions. Planned start Oct 2020; status: not yet recruiting.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on ChiCTR2000034920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000034920.